These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38530518)

  • 1. Use of nebulized liposomal amphotericin B and posaconazole as antifungal prophylaxis in patients with severe SARS-CoV2 infection in intensive care unit.
    Fumarola B; Signorini L; Lorenzotti S; Lanza P; Saccani B; Van Hauwermeiren E; Mulè A; Piva S; Rota M; Zuccalà F; Rasulo FA; Filippini M; Bertazzoli A; Del Fabro G; Matteelli A
    Infection; 2024 Aug; 52(4):1459-1468. PubMed ID: 38530518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nebulized Amphotericin B in Mechanically Ventilated COVID-19 Patients to Prevent Invasive Pulmonary Aspergillosis: A Retrospective Cohort Study.
    Melchers M; van Zanten ARH; Heusinkveld M; Leeuwis JW; Schellaars R; Lammers HJW; Kreemer FJ; Haas PJ; Verweij PE; van Bree SHW
    Crit Care Explor; 2022 May; 4(5):e0696. PubMed ID: 35558738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal prophylaxis with nebulized amphotericin-B in solid-organ transplant recipients with severe COVID-19: a retrospective observational study.
    Rombauts A; Bodro M; Daniel Gumucio V; Carbonell I; Favà À; Lladó L; González-Costello J; Oppenheimer F; Castel-Lavilla MÁ; Len O; Marquez-Algaba E; Nuvials-Casals X; Martínez González D; Lacasa JS; Carratalà J; Sabé N
    Front Cell Infect Microbiol; 2023; 13():1165236. PubMed ID: 37180450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.
    Hatzl S; Reisinger AC; Posch F; Prattes J; Stradner M; Pilz S; Eller P; Schoerghuber M; Toller W; Gorkiewicz G; Metnitz P; Rief M; Prüller F; Rosenkranz AR; Valentin T; Krause R; Hoenigl M; Schilcher G
    Crit Care; 2021 Sep; 25(1):335. PubMed ID: 34526087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis.
    Frost J; Gornicec M; Reisinger AC; Eller P; Hoenigl M; Prattes J
    Mycopathologia; 2024 Jan; 189(1):3. PubMed ID: 38217742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary
    ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):10-23. PubMed ID: 38062689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.
    Gangneux JP; Dannaoui E; Fekkar A; Luyt CE; Botterel F; De Prost N; Tadié JM; Reizine F; Houzé S; Timsit JF; Iriart X; Riu-Poulenc B; Sendid B; Nseir S; Persat F; Wallet F; Le Pape P; Canet E; Novara A; Manai M; Cateau E; Thille AW; Brun S; Cohen Y; Alanio A; Mégarbane B; Cornet M; Terzi N; Lamhaut L; Sabourin E; Desoubeaux G; Ehrmann S; Hennequin C; Voiriot G; Nevez G; Aubron C; Letscher-Bru V; Meziani F; Blaize M; Mayaux J; Monsel A; Boquel F; Robert-Gangneux F; Le Tulzo Y; Seguin P; Guegan H; Autier B; Lesouhaitier M; Pelletier R; Belaz S; Bonnal C; Berry A; Leroy J; François N; Richard JC; Paulus S; Argaud L; Dupont D; Menotti J; Morio F; Soulié M; Schwebel C; Garnaud C; Guitard J; Le Gal S; Quinio D; Morcet J; Laviolle B; Zahar JR; Bougnoux ME
    Lancet Respir Med; 2022 Feb; 10(2):180-190. PubMed ID: 34843666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-Associated Pulmonary Aspergillosis (CAPA).
    Dimopoulos G; Almyroudi MP; Myrianthefs P; Rello J
    J Intensive Med; 2021 Oct; 1(2):71-80. PubMed ID: 36785564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19-associated pulmonary aspergillosis is associated with increased in-hospital mortality and prolonged SARS-CoV-2 viral shedding.
    Huang JR; Shen HC; Sun CY; Chen WC; Chen YM; Feng JY; Yang KY
    J Formos Med Assoc; 2022 Dec; 121(12):2617-2625. PubMed ID: 35953342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
    Erami M; Hashemi SJ; Raiesi O; Fattahi M; Getso MI; Momen-Heravi M; Daie Ghazvini R; Khodavaisy S; Parviz S; Mehri N; Babaei M
    Infection; 2023 Feb; 51(1):223-230. PubMed ID: 36107379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave.
    Bentvelsen RG; Arkel ALEV; Rijpstra TA; Kant MKM; Brugge SVS; Loth DW; Van Wijngaarden P; Mée AWFD; Yick DCY; Diederen BMW; Wever PC; Leenders ACAP; Van Dommelen L; Groot KH; Van den Bijllaardt W; Verweij PE
    J Fungi (Basel); 2022 Jan; 8(2):. PubMed ID: 35205851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Tale of Two Hospitals: Comparing CAPA Infections in Two ICUs During the Spanish Fourth Pandemic Wave.
    Sánchez-Castellano MÁ; Marcelo C; Marco J; Figueira-Iglesias JC; García-Rodríguez J
    Mycopathologia; 2023 Aug; 188(4):335-344. PubMed ID: 37256502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave.
    Bretagne S; Sitbon K; Botterel F; Dellière S; Letscher-Bru V; Chouaki T; Bellanger AP; Bonnal C; Fekkar A; Persat F; Costa D; Bourgeois N; Dalle F; Lussac-Sorton F; Paugam A; Cassaing S; Hasseine L; Huguenin A; Guennouni N; Mazars E; Le Gal S; Sasso M; Brun S; Cadot L; Cassagne C; Cateau E; Gangneux JP; Moniot M; Roux AL; Tournus C; Desbois-Nogard N; Le Coustumier A; Moquet O; Alanio A; Dromer F;
    Microbiol Spectr; 2021 Oct; 9(2):e0113821. PubMed ID: 34668768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticipatory Antifungal Treatment in Critically Ill Patients with SARS-CoV-2 Pneumonia.
    Estella Á; Recuerda Núñez M; Lagares C; Gracia Romero M; Torres E; Alados Arboledas JC; Antón Escors Á; González García C; Sandar Núñez D; López Prieto D; Sánchez Calvo JM
    J Fungi (Basel); 2023 Feb; 9(3):. PubMed ID: 36983456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19-associated pulmonary aspergillosis in patients with severe SARS-CoV-2 infection: A single-center observational study from Greece.
    Ouranos K; Tsakiri K; Massa E; Dourliou V; Mouratidou C; Soundoulounaki S; Mouloudi E
    Ann Thorac Med; 2023; 18(3):116-123. PubMed ID: 37663880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suboptimal plasma concentrations with posaconazole suspension as prophylaxis in critically ill COVID-19 patients at risk of Covid-associated pulmonary aspergillosis.
    Mian P; Trof RJ; Beishuizen A; Masselink JB; Cornet AD; Sportel ET
    J Clin Pharm Ther; 2022 Mar; 47(3):383-385. PubMed ID: 34431552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series.
    Meijer EFJ; Dofferhoff ASM; Hoiting O; Meis JF
    Mycoses; 2021 Apr; 64(4):457-464. PubMed ID: 33569857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic.
    Er B; Er AG; Gülmez D; Şahin TK; Halaçlı B; Durhan G; Ersoy EO; Alp A; Metan G; Saribas Z; Arikan-Akdagli S; Hazırolan G; Akıncı SB; Arıyürek M; Topeli A; Uzun Ö
    Mycoses; 2022 Jul; 65(7):724-732. PubMed ID: 35531631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
    Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
    Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary Aspergillosis in Critically Ill COVID-19 Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study.
    Bergmann F; Jorda A; Blaschke A; Gabler C; Bohdan S; Nussbaumer-Pröll A; Radtke C; Zeitlinger M
    J Fungi (Basel); 2023 Mar; 9(3):. PubMed ID: 36983483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.